Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2026-05-15 @ 5:47 PM
Study NCT ID:
NCT05253118
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-15
First Post:
2022-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
Sponsor:
Seoul National University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SPECTRUM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None